2023

Chankeaw K, Kamolratanakul S , Tapaopong J , Pitisuttithum P , Dhitavat J , Picheansoonthon C (2023) “Efficacy of a Thai Herbal Remedy in Patients with Mild Chronic Plaque Psoriasis: An Observer-Blinded Randomized, Standard Treatment-Controlled Trial” J Med Assoc Thai; 106 (7):690-6.

Jaita S, Pisutsan P, Lawpoolsri S, Kitro A, Kittitrakul C, Kusolsuk T, Kamolratanakul S, Chompoosri P, Flaherty GT, Dhitavat J (2023) “International University Students' Pre-Travel Preparation, Knowledge and Practices towards Travel Health in Thailand: A Nationwide Cross-Sectional Study.” Trop Med Infect Dis. 2023 Jun 15;8(6):322. doi: 10.3390/tropicalmed8060322.

Adam S, Dekumyoy P, Nacapunchai D, Ketboonlue T, Charunwatthana P, Dhitavat J, Koompapong K, Chonsawat P, Watthanakulpanich D. (2023) “Assessment of an Immuno-Diagnostic Method for Hookworm-Related Cutaneous Larva Migrans Using Crude Extracts of Ancylostoma caninum.” Trop Med Infect Dis. Mar 30;8(4):209. doi: 10.3390/tropicalmed8040209.

Horvath A, Rogers L, Pollakis G, Baranov O, Pieroth N, Joseph S, Chachage M, Heitzer A, Maganga L, Msafiri F, Joachim A, Viegas E, Eller LA, Kibuuka H, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Dhitavat J, Premsri N, Fidler S, Shattock RJ, Robb ML, Weber J, McCormack S, Munseri PJ, Lyamuya E, Nilsson C, Kroidl A, Hoelscher M, Wagner R, Geldmacher C, Held K. (2023) “Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?” Front Immunol. Jan 9;13:1075606. doi: 10.3389/fimmu.2022.1075606.

2021

Wansom T, Muangnoicharoen S, Nitayaphan S, Kitsiripornchai S, Crowell TA, Francisco L, Gilbert P, Rwakasyaguri D, Dhitavat J, Li Q, King D, Robb ML, Smith K, Heger EA, Akapirat S, Pitisuttithum P, O'Connell RJ, Vasan S. (2021) “Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand.” EClinicalMedicine. Jul 17;38:101033. doi: 10.1016/j.eclinm.2021.101033.

Pitisuttithum P, Dhitavat J, Sirivichayakul C, Pitisuthitham A, Sabmee Y, Chinwangso P, Kerdsomboon C, Fortuna L, Spiegel J, Chauhan M, Poredi IK, van den Biggelaar AHJ, Wijagkanalan W, Viviani S, Mansouri S, Pham HT. (2021) “Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines.” EClinicalMedicine. Jun 23;37:100976. doi: 10.1016/j.eclinm.2021.100976.

2020

Atsawawaranunt K, Kittiyaowamarn R, Phonrat B, Kamolratanakul S, Kangvalpornroj T, Dhitavat J (2020). “Time to serological cure and associated factors among syphilis patients with and without hiv in a sexually transmitted infections center, Thailand.” Sex Transm Dis. 2020 Mar 5. doi: 10.1097/OLQ.0000000000001154.

Kamolratanakul S, Sommanus S, Lawpoolsri S, Matsee W, Mansanguan C, Dhitavat J. Dermatological conditions of travelers returning to Thailand from travel abroad: A prospective study. Southeast Asian Journal of Tropical Medicine and Public Health. 2020 Nov;51(6):844-53.

Pitisuttithum P, Nitayaphan S, Chariyalertsak S, Kaewkungwal J, Dawson P, Dhitavat J, Phonrat B, Akapirat S, Karasavvas N, Wieczorek L, Polonis V, Eller MA, Pegu P, Kim D, Schuetz A, Jongrakthaitae S, Zhou Y, Sinangil F, Phogat S, Diazgranados CA, Tartaglia J, Heger E, Smith K, Michael NL, Excler JL, Robb ML, Kim JH, O'Connell RJ, Vasan S; RV306 study group (2020). “Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial” Lancet HIV. Feb 6. pii: S2352-3018(19)30406-0. doi: 10.1016/S2352-3018(19)30406-0. [Epub ahead of print].

2018

Pitisuttithum P, Chokephaibulkit K, Sirivichayakul C, Sricharoenchai S, Dhitavat J, Pitisuthitham A, Phongsamart W, Boonnak K, Lapphra K, Sabmee Y, Wittawatmongkol O, Chauhan M, Wijagkanalan W, Hommalai G, Fortuna L, Chinwangso P, Poredi IK, van den Biggelaar AHJ, Pham HT, Viviani S. (2018) “Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.” Lancet Infect Dis. Sep 25: doi: 10.1016/S1473-3099(18)30375-X. [Epub ahead of print]

Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, Phongsamart W, Boonnak K, Lapphra K, Sabmee Y, Wittawatmongkol O, Chinwangso P, Poredi IK, Petre J, Thai PH, Viviani S*. A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial. Lancet Infectious Diseases. 2018 Jan 18(1): 58-67

2017

Boonnak K, Dhitavat J, Thantamnu N, Kosoltanapiwat N, Auayporn M, Jiang L, Puthavathana P, Pitisuttithum P.(2017) “Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.” Vaccine.35(52):7339-7346.

Charoenwatanachokchai A, Marin N, Phonrat B, Dhitavat J. (2017) “Partner notification outcomes among male gonorrhea patients at Bangkok Hospital, Bangkok, Thailand.” Southeast Asian J Trop Med Public Health.48 (2): 367-375.

Kamolratanakul S, Dhitavat J. Disseminatd herpes zoster in immunocompetent host : a rare case report and review of the literature. that J dermatol 2017; 33: 215-222.

Rampakakis E, Stutz M, Kawai K, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Cashat-Cruz M, Monsanto H, Johnson K, Sampalis JS, Acosta CJ. (2017) “Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.” Health Qual Life Outcomes. 15(1): 11.

Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, Phongsamart W, Boonnak K, Lapphra K, Sabmee Y, Wittawatmongkol O, Chinwangso P, Poredi IK, Petre J, Thai PH, Viviani S.(2017) “A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.” Lancet Infect Dis.18(1):58-67.

2016

Martinez Vega R, Phumratanaprapin W*, Phonrat B, Dhitavat J, Sutherat M, Choovichian V. Differences in Liver Impairment Between Adults and Children with Dengue Infection. American Journal of Tropical Medicine and Hygiene. 2016 May 94(5): 1073-9

Pitisuttithum P*, Islam D, Chamnanchanunt S, Ruamsap N, Khantapura P, Kaewkungwal J, Kittitrakul C, Luvira V, Dhitavat J, Venkatesan MM, Mason CJ, Bodhidatta L. A clinical trial of an oral live Shigella sonnei vaccine candidate, WRSS1, in Thai adults. Clinical and Vaccine Immunology.2016 Jul 23(7):564-75

Worasathit R, Wattana W, Okanurak K, Songthap A, Dhitavat J, Pitisuttithum P. (2016) “Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults.” BMC Geriatrics.15(1):136.

2015

Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, Sampalis JS, Acosta CJ.(2015)“Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.” Int J Infect Dis. 34:126-31.

Worasathit R, Wattana W, Okanurak K, Songthap A, Dhitavat J, Pitisuttithum P.Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults. BMC Geriatr. 2015 Oct 15(1):136.

2014

Yeekian C, Geratikornsupak N, Chumpongthong P, Tongsiri S, Dhitavat J, Phonrat B, Pitisuttithum P.(2014) “Medical and economic burden of chronic hepatitis B patients at Queen Savang Vadhana Memorial Hospital.” J Med Assoc Thai. 97(4):447-55.

Khowsroy K, Dhitavat J, Sabmee Y, Laowarakul P, Wattanakitwichai J, Auetian J, Lothong K, Boondao R, Maythaarttaphong S, Yaemwong S, Excler JL, Rerks-Ngarm S, Pitisuttithum P.(2014) “Expectation of volunteers towards the vaccine efficacy of the prime-boost HIV vaccine phase III trial during unblinding.” AIDS Res Hum Retroviruses.30(11):1041-5.

2013

Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, Nitayaphan S, Khamboonruang C, Kunasol P, Suntharasamai P, Pungpak S, Vanijanonta S, Bussaratid V, Maek-A-Nantawat W, Dhitavat J, Thongcharoen P, Pawarana R, Sabmee Y, Benenson MW, Morgan P, O' Connell RJ, Kim J. (2013) “Issues in women's participation in a phase III community HIV vaccine trial in Thailand” AIDS Res Hum Retroviruses 29(11):1524-34.

Phonrat B, Pitisuttithum P, Chamnanchanunt S, Puthavathana P, Ngaosuwankul N, Louisirirotchanakul S, Dhitavat J, Thirapakpoomanunt S, Chokevivat V, Wibulpolprasert S. (2013) “Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais” Vaccine 31(11):1503-9.

2012

de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, Valencia-Micolta A, Thelian D, Nitayaphan S, Pitisuttithum P, Paris RM, Kaewkungwal J, Michael NL, Rerks-Ngarm S, Mathieson B, Marovich M, Currier JR, Kim JH, Bussaratid V, Dhitavat J; Ministry of Public Health–Thai AIDS Vaccine Evaluation Group Collaborators. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope. journal of immunol. 2012 May 15;88(10):5166-76

2011

Aunhachoke K, Bussaratid V, Chirachanakul P, Chua-Intra B, Dhitavat J, Jaisathaporn K, Kaewkungwal J, Kampirapap K, Khuhaprema T, Pairayayutakul K, Pitisuttithum P, Sindhvananda J, Thaipisuttikul Y; Thai Herpes Zoster Study Group. (2011) Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand.Int J Dermatol. 50(4): 428-35.

Desakorn V, Karmacharya BM, Thanachartwet V, Kyaw NL, Tansuphaswadikul S, Sahassananda D, Dhitavat J, Maek-a-nantawat W, Pitisuttithum P.(2011) “Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.” Southeast Asian J Trop Med Public Health. 42(6):1414-22.

Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, Benenson M, Morgan P, O'Connell RJ, Berenberg J, Gurunathan S, Francis DP, Paris R, Chiu J, Stablein D, Michael NL, Excler JL, Robb ML, Kim JH.(2011) “Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.” PLoS One.(12):e27837. doi: 10.1371/journal.pone.0027837. Epub 2011 Dec 21.

Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, Benenson M, Morgan P, O'Connell RJ, Berenberg J, Gurunathan S, Francis DP, Paris R, Chiu J, Stablein D, Michael NL, Excler JL, Robb ML, Kim JH.(2011) Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148).Vaccine.29(25):4285-92.

2009

Maek-a-nantawat W, Phonrat B, Dhitavat J, Naksrisook S, Muanaum R, Ngamdee V, Pitisuttithum P. Safety and efficacy of CKBM-A01, a Chinese herbal medicine, among asymptomatic HIV patients. Southeast Asian J Trop Med Public Health. 2009;40(3):494-501.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators. (2009) “Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.” N Engl J Med.361(23):n 2209-20.

2012

Capability Assessment for Supporting Research and Development of Vaccine in Thailand

2008

Chamnachanan S, Tu A K, Tansuphasawadiku S, Phonrat B, Pitisuttithum P, Dhitavat J. Pulmonary tuberculosis treatment outcomes in HIV infected patients on antiretroviral therapy. International journal of infectious diseases, 2008 Jun 2; 12: s23-s23,52 suppl.

2007

Tansuphasawadikul S, Saito W, Kim J, Phonrat B, Dhitavat J, Chamnachanan S, Pitisuttithum P. (2007) “Outcomes in HIV-infected patients on Antiretroviral Therapy with Tuberculosis.” Southeast Asian J Trop Med Public Health 38 (6): 1053-60.

2006

Getahun A, Tansuphaswadikul S, Desakorn V, Dhitavat J, Pitisuttithum P.(2006).Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir®) in advanced HIV infection. J Med Thai Assoc.89 (9): 1472-8.

2004

Cooper SM, Dhitavat J, Millard P, Burge S. (2004) “Extensive Grover's-like eruption with lentiginous 'freckling': report of two cases.” Br J Dermatol. 150(2):350-2.

Dhitavat J, Fairclough RJ, Hovnanian A, Burge S. (2004). “Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease.” Br J Dermatol 150(5): 821-8. Review.

Millard TP, Dhitavat J, Hollowood K, Burge S. (2004) “ ‘Groveroid’ Darier’s disease.” Br J Dermatol. 150(3):600-2.

2003

Dhitavat J, Cobbold C, Leslie N, Burge S, Hovnanian A. (2003). “Impaired desmoplakin trafficking in cultured Darier’s disease keratinocytes.” J Invest Dermatol 121(6): 1349-55.

Dode L, Andersen JP, Leslie N, Dhitavat J, Vilsen B, Hovnanian A. (2003). “Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.” J Biol Chem 278(48): 47877-89.

Dhitavat J, Dode L, Leslie N, Sakuntabhai A, Lorette G, Hovnanian A. (2003). “Mutations in the SERCA2b isoform cause Darier's disease.” J Invest Dermatol 121(3): 486-9.

Dhitavat J, Macfarlane S, Dode L, Leslie N, Sakuntabhai A, McSween R, Saihan E, Hovnanian A. (2003). “Acrokeratosis verruciformis of Hopf is caused by mutation in ATP2A2: evidence that it is allelic to Darier’s disease.” J Invest Dermatol 120(2): 229-32.

2000

Dhitavat J. MSc Thesis: Sebum excretion rate in acne and acne free persons. Chulalongkorn University, Thailand

Sakuntabhai A*, Dhitavat J*, Burge S, Hovnanian A. (2000). “Mosaicism for ATP2A2 mutations causes segmental Darier’s disease.” J Invest Dermatol 115 (6): 1144-7. *These authors contributed equally to the work.